Evolution of bovine viral diarrhea virus vaccines

Veterinary Clinics of North America - Food Animal Practice

Volumn 20, Issue 1, 2004, Pages 115-129

  Kelling, Clayton L ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INACTIVATED VACCINE; LIVE VACCINE; MATERNAL ANTIBODY; NEUTRALIZING ANTIBODY; VIRUS VACCINE;

BEEF CATTLE; BOVINE DIARRHEA VIRUS; CATTLE DISEASE; CELLULAR IMMUNITY; CLINICAL FEATURE; CROSS REACTION; DAIRY CATTLE; DISEASE SEVERITY; DISEASE TRANSMISSION; DRUG CHOICE; DRUG EFFICACY; EVOLUTION; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INFECTION CONTROL; INTRAUTERINE INFECTION; NONHUMAN; RESPIRATORY TRACT INFECTION; REVIEW; SPECIES DIVERSITY; STRAIN DIFFERENCE; VACCINATION; VIRUS INFECTION; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS VIRULENCE;

ANIMALS; BOVINE VIRUS DIARRHEA-MUCOSAL DISEASE; CATTLE; DIARRHEA VIRUSES, BOVINE VIRAL; DISEASE TRANSMISSION; VACCINES, ATTENUATED; VARIATION (GENETICS); VIRAL VACCINES; VIRULENCE;

BOS TAURUS; BOVINAE; BOVINE VIRAL DIARRHEA VIRUS 1;

EID: 2342557051     PISSN: 07490720     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cvfa.2003.11.001     Document Type: Review

References (67)

1. Collett M, Anderson D, Retzel E. Comparisons of the pestivirus bovine viral diarrhea virus with members of the Flaviviridae. J Gen Virol 1988;69:2637-43.
2. Howard C, Brownlie J, Clarke M. Comparison by the neutralization assay of pairs of noncytopathogenic and cytopathogenic strains of bovine virus diarrhea virus isolated from cases of mucosal disease. Vet Microbiol 1987;13:361-9.
3. Donis R, Corapi W, Dubovi E. Bovine viral diarrhea virus and their antigenic analysis. Arch Virol 1991;(Suppl 3):29-40.
4. Pellerin C, Van Den Hurk J, Lecomte J, Tijssen P. Identification of a new group of bovine viral diarrhea virus strains associated with severe outbreaks and high mortalities. Virology 1994;203:260-8.
5. Ridpath J, Bolin S, Dubovi E. Segregation of bovine viral diarrhea virus into gentoypes. Virology 1994;205:66-74.
6. Ridpath J, Bolin S. Differentiation of types 1a, 1b, and 2 bovine viral diarrhea virus (BVDV) by PCR. Mol Cell Probes 1998;12:101-6.
7. Kelling C, Steffen D, Topliff C, Eskridge K, Donis R, Higuchi D. Comparative virulence of isolates of bovine viral diarrhea virus type II in experimentally inoculated six- to nine-month-old calves. Am J Vet Res 2002;63:1379-84.
8. Moennig V, Liess B. Pathogenesis of intrauterine infections with bovine viral diarrhea virus. Vet Clin North Am Food Anim Prac 1995;11:477-87.
9. Grooms D, Brock K, Ward L. Detection of bovine viral diarrhea virus in the ovaries of cattle acutely infected with bovine viral diarrhea virus. J Vet Diagn Invest 1998;10:125-9.
10. Swasdipan S, McGowan M, Phillips N, Bielefeldt-Ohmann H. Pathogenesis of transplacental virus infection: pestivirus replication in the placenta and fetus following respiratory infection. Micro Pathogen 2002;32:49-60.
11. Brock K, Grooms D, Ridpath J, Bolin S. Changes in levels of viremia in cattle persistently infected with bovine viral diarrhea virus. J Vet Diagn Invest 1998;10:22-6.
12. Fray M, Supple E, Morrison W, Charleston B. Germinal center localization of bovine viral diarrhoea virus in persistently infected animals. J Gen Virol 2000;81:1669-73.
13. Kelling C, Stine L, Rump K, Parker R, et al. Investigation of bovine viral diarrhea virus infections in a range beef cattle herd. J Am Vet Med Assoc 1990;197:589-93.
14. Stokstad M, Loken T. Pestivirus in cattle: experimentally induced persistent infection in calves. J Vet Med B 2002;49:494-501.
15. Wittum T, Grotelueschen D, Brock K, Kvasnicka W, Floyd J, Kelling C, et al. Persistent bovine viral diarrhoea virus infection in US beef herds. Prev Vet Med 2001;49:83-94.
16. Baker J. Clinical aspects of bovine virus diarrhoea virus infection. Rev Sci Tech Off Int Epiz 1990;9:25-41.
17. Bolin S, McClurkin A, Cutlip R. Severe clinical disease in cattle persistently infected with noncytopathic bovine viral diarrhea virus by super-infection with cytopathic bovine viral diarrhea virus. J Vet Res 1998;46:573-6.
18. Qi I, Ridpath J, Lewis T, Bolin S, Berry E. Analysis of the bovine viral diarrhea virus genome for possible cellular insertions. Virol 1992;189:285-92.
19. Brown T, DeLahunta A, Scott F, Kahus R, McEntee K, Gillespie J. Virus induced congenital abnormalities of the bovine fetus. Histopathology of cerebellar degeneration (hypoplasia) induced by the virus of bovine viral diarrhea-mucosal disease. Cornell Vet 1074;63:561-78.
20. Brodersen B, Kelling C. Effect of experimentally induced concurrent bovine respiratory syncytial virus and bovine viral diarrhea virus infections on respiratory and enteric diseases in calves. Am J Vet Res 1998;59:1423-30.
21. Brownlie J. The pathways for bovine virus diarrhoea virus biotypes in the pathogenesis of disease. Arch Virol 1991;(Suppl 3):79-99.
22. Coria M, McClunkin A. Specific immune tolerance in an apparently healthy bull persistently infected with BVD Virus. J Am Vet Med Assoc 1978;172:449-51.
23. Carman S, van Dreumel T, Ridpath J, Hazlett M, Alves D, Dubovi E, et al. Severe acute bovine viral diarrhea in Ontario, 1993-1995. J Vet Diagn Invest 1998;10:27-35.
24. Corapi W, French T, Dubovi E. Severe thrombocytopenia in young calves experimentally infected with noncytopathic bovine viral diarrhea virus. J Virol 1989;63:3934-43.
25. Fulton R, Ridpath J, Saliki J, Briggs R, Confer A, Burge L, et al. Bovine viral diarrhea virus (BVDV) 1b: predominant BVDV subtype in calves with respiratory disease. Can J Vet Res 2002;66:181-90.
26. Martin W, Nagy E, Armstrong D, Rosendal S. The association of viral and mycoplasmal antibody titrs with respiratory disease and weight gain in feedlot calves. Can Vet J 1999;40:560-70.
27. Haines D, Martin K, Clark E, Jim G, Jansen E. The immunohistochemical detection of Mycoplasma bovis and bovine viral diarrhea virus in tissues of feedlot cattle with chronic, unresponsive respiratory disease and/or arthritis. Can Vet J 2001;42:857-60.
28. Ohmann H, Ronsholt L, Bloch B. Demonstration of bovine viral diarrhea virus in peripheral blood mononuclear cells of persistently infected, clinically normal cattle. J Gen Virol 1987;68:1971-2.
29. Larrson B. A cellular analyses of immunosuppression in cattle with mucosal disease. Res Vet Sci 1988;44:71-5.
30. Roth J, Bolin S, Frand D. Lymphocytic blastogenesis and neutrophil function in cattle persistently infected with bovine viral diarrhea virus. Am J Vet Res 1986;47:1139-41.
31. Ketelsen A, Johnson D, Muscoplat C. Depression of monocyte chemotactic responses by bovine viral diarrhea viruses. Infect Immun 1979;25:565-8.
32. Werdin R, Ames T, Goyal S, DeVries G. Diagnostic investigation of bovine viral diarrhea infection in a Minnesota diary herd. J Vet Diagn Invest 1989;1:57-61.
33. Kelling C, Steffen D, Cooper V, Higuchi D, Eskridge K. Effect of infection with bovine viral diarrhea virus alone, bovine rotavirus alone, or concurrent infection with both on enteric disease in gnotobiotic calves. Am J Vet Res 2002;63:1179-86.
34. Murphy B, Chanock R. Immunization against viruses. In: Fields BN, Knipe D, Howley P, editors. Field's Virology. 4th edition. New York: Raven Press; 2001. p. 435-67.
35. + T cells in response to bovine viral diarrhoea virus in cattle. J Gen Virol 1999;80:1673-9.
36. + T-cell responses to bovine viral diarrhoea virus in cattle. Virus Res 2000;67:67-80.
37. Brock JV, Cortese VS. Experimental fetal challenge using Type II bovine viral diarrhea virus in cattle vaccinated with modified-live virus vaccine. Vet Ther 2001;2:354-60.
38. Potgieter L. Immunology of bovine viral diarrhea virus. Bovine viral diarrhea virus. Vet Clin N Am Food Anim Pract 1995;11:501-20.
39. Bolin S. Immunogens of bovine viral diarrhea virus. Vet Microbiol 1993;37:263-71.
40. Bolin S, Ridpath J. Specificity of neutralizing and precipitating antibodies induced in healthy calves by monovalent modified-live bovine viral diarrhea virus vaccines. Am J Vet Res 1989;50:817-21.
41. Cortese V, Whittaker R, Ellis J, Ridpath J, Bolin S. Specificity and duration of neutralizing antibodies induced in healthy cattle after administration of a modified-live virus vaccine against bovine viral diarrhea. Am J Vet Res 1998;59:848-50.
42. Fairbanks K, Shnackel J, Chase C. Evaluation of a modified live virus type-1 bovine viral diarrhea virus (Singer strain) against a type-2 (Strain 890) challenge. Vet Ther 2003;4:24-34.
43. Ellis J, West K, Cortese V, Knooby C, Weigel D. Effect of maternal antibodies on induction and persistence of vaccine-induced immune responses against bovine viral diarrhea virus type II in young calves. J Am Vet Med Assoc 2001;219:351-6.
44. Dean H, Leyh R. Cross-protective efficacy of a bovine viral diarrhea virus (BVDV) type 1 vaccine against BVDV type 2 challenge. Vaccine 1999;17:1117-24.
45. Fulton R, Burge L. Bovine viral diarrhea virus types 1 and 2 antibody response in calves receiving modified live virus or inactivated vaccines. Vaccine 2000;19:264-74.
46. Dubovi E. Fetal infection may not be preventable with BVDV vaccines. Comp Immun Microbiol Infect Dis 1992;15:155-62.
47. Van Campen H, Huzurbazar S, Edwards J, Cavender JL. Distribution of antibody titers to bovine viral diarrhea virus in infected, exposed, and uninfected beef cattle. J Vet Diagn Invest 1998;10:183-6.
48. Van Oirschot J, Bruschke C, van Rijn P. Vaccination of cattle against bovine viral diarrhoea. Vet Micro 1999;64:169-83.
49. Van Campen H, Vorpahl P, Huzurbazar S, Edwards J, Cavender J. A case report: evidence for type 2 bovine viral diarrhea virus (BVDV)-associated disease in beef herds vaccinated with a modified-live type 1 BVDV vaccine. J Vet Diagn Invest 2000;12:263-5.
50. Cortese V, Grooms D, Ellis J, Bolin S, Ridpath J, Brock K. Protection of pregnant cattle and their fetuses against infection with bovine viral diarrhea virus type 1 by use of a modified-live virus vaccine. Am J Vet Res 1998;59:1409-11.
51. Ellsworth M, Kelling C, Dickinson E, Cravens R, Eide E. Fetal infection following intravenous bovine viral diarrhea virus challenge of vaccinated and nonvaccinated dams. Presented at Conference of Research Workers in Animal Diseases [abstract]. 1993.
52. Dean H, Hunsaker D, Bailey D, Wasmoen T. Prevention of persistent infection in calves by vaccination of dams with noncytpathic type-1 modified live bovine viral diarrhea virus prior to breeding. Am J Vet Res 2003;64:530-7.
53. Frey H, Eicken K, Grummer B, Kenklies S, Oguzoglu T, Moennig V. Foetal protection against bovine viral diarrhea virus. J Vet Med B 2002;49:489-93.
54. Van Oirschot J, Bruschke C, van Rijn P. Vaccination of cattle against bovine viral diarrhoea. Vet Microbiol 1999;64:169-83.
55. Roth J, Kaeberle M. Suppression of neutrophil and lymphocyte function induced by a vaccinal strain of bovine viral diarrhea virus with and without the administration of ACTH. Am J Vet Res 1982;44:2366-72.
56. Fulton R, Saliki J, Burge L, Payton M. Humoral immune response and assessment of vaccine virus shedding in calves receiving modified live virus vaccines containing bovine herpesvirus-1 and bovine viral diarrhea virus 1a. J Vet Med B 2003;50:31-7.
57. Hunsaker B, Topli. C, Achenbach J, Kelling C. Back-passage of a commercial modified-live vaccine (MLV) strain of type 1 noncytopathic bovine viral diarrhea virus did not result in reversion to virulence. Presented at Conference of Research Workers in Animal Diseases. 2002.
58. Barkema H, Bartels C, van Wuijckhuise L, Hesselink J, Holzhauer M, Weber M, et al. Outbreak of bovine virus diarrhoea on Dutch dairy farms induced by a bovine herpesvirus 1 marker vaccine contaminated with bovine virus diarrhoea virus type 2. Tijdschrift voor Dierg 2001;126:158-65.
59. Vilcek S. Identification of pestiviruses contaminating cell lines and fetal calf sera. Acta Virol 2001;45:81-6.
60. Wessman S, Levings R. Benefits and risks due to animal serum used in cell culture production. Dev Biol Stand 1999;99:3-8.
61. Bolin S, Ridpath J. Prevalence of bovine viral diarrhea virus genotypes and antibody against those viral genotypes in fetal bovine serum. J Vet Diagn Invest 1998;10:135-9.
62. Audet S, Crim R, Beeler J. Evaluation of vaccines, interferons and cell substrates for pestivirus contamination. Biologicals 2000;28:41-6.
63. Kelling C, Grotelueschen D, Smith D, Brodersen B. Testing and management Ttrategies for effective beef and dairy herd BVDV biosecurity programs. Bovine Practitioners 2000;34:13-22.
64. Bolin S., Ridpath J. Assessment of protection from systemic infection or disease afforded by low to intermediate titers of passively acquired neutralizing antibody against bovine viral diarrhea virus in calves. Am J Vet Res. 56:1995;755-759
65. Bolin S, Ridpath J. Assessment of protection from systemic infection or disease afforded by low to intermediate titers of passively acquired neutralizing antibody against bovine viral diarrhea virus in calves. Am J Vet Res 1995;56:755-9.
66. Grooms D, Coe P. Neutralizing antibody responses in preconditioned calves following vaccination for respiratory viruses. Vet Ther 2002;2:119-27.
67. Mcguire T, Pfeiffer N, Weikel J, Bartsch R. Failure of colostral immunoglobulin transfer in calves dying from infectious disease. J Am Vet Med Assoc 1976;169:713-8.